ERICA DEANGELO: Open Payments
NPI 1134694946 · REDONDO BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,542 in 92 payments from 13 companies in 2025. Trend: 2023 $111 · 2024 $1,968 · 2025 $2,542
Food & beverage: $2,542
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 18 | $576 |
| Galderma Laboratories, L.P. | 19 | $325 |
| Arcutis Biotherapeutics, Inc. | 8 | $311 |
| GENZYME CORPORATION | 11 | $308 |
| ABBVIE INC. | 5 | $188 |
| UCB, Inc. | 4 | $169 |
| Novartis Pharmaceuticals Corporation | 6 | $141 |
| Janssen Biotech, Inc. | 5 | $111 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Lilly USA, LLC | 4 | $100 |
Products named: OPZELURA, DUPIXENT, Zoryve, NEMLUVIO, SKYRIZI, Bimzelx, COSENTYX, TREMFYA.
Industry payments across CA — which companies pay providers there.
